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Bacterial binding protein-dependent ATP binding cassette (ABC)
transporters facilitate uptake of essential nutrients. The crystal
structure of Escherichia coli BtuF, the protein that binds vitamin B12
and delivers it to the periplasmic surface of the ABC transporter
BtuCD, reveals a bi-lobed fold resembling that of the ferrichrome
binding protein FhuD. B12 is bound in the ‘‘base-on’’ conformation
in a deep cleft formed at the interface between the two lobes of
BtuF. A stable complex between BtuF and BtuCD (with the stoi-
chiometry BtuC2D2F) is demonstrated to form in vitro and was
modeled using the individual crystal structures. Two surface glu-
tamates from BtuF may interact with arginine residues on the
periplasmic surface of the BtuCD transporter. These glutamate and
arginine residues are conserved among binding proteins and ABC
transporters mediating iron and B12 uptake, suggesting that they
may have a role in docking and the transmission of conformational
changes.
ATP binding cassette (ABC) transporters are a ubiquitousfamily of importer and exporter proteins that invariably
consist of two membrane-spanning domains, which form a
translocation pathway, and two cytoplasmic ABC domains,
which power the transport reaction through binding and hydro-
lysis of ATP (1). Although most eukaryotic ABC transporters
export hydrophobic molecules from the cytoplasm (2), the
majority of bacterial ABC transporters import essential nutrients
that are delivered to them by specific binding proteins (1, 3, 4).
These proteins bind their substrates selectively and with high
affinity, which is thought to ensure the specificity of the transport
reaction (3). The association of a substrate-loaded binding
protein with its cognate transporter has been shown to stimulate
ATP hydrolysis by the cytoplasmic ABC domains (5). The
binding protein remains docked to the cognate transporter until
one or both of the hydrolysis products are released, as shown by
experiments that used vanadate to trap an intermediate close to
the transition state (6). This finding suggested that the binding
protein, associated with the transporter during substrate trans-
location, may prevent the escape of substrate into the periplas-
mic space.
The structures of many different binding proteins have been
solved, revealing a common architecture: two domains, each
consisting of a central -sheet and surrounding -helices, with
the substrate binding site located in a cleft between them (7).
Recently, the crystal structure of the binding protein-dependent
ABC transporter, BtuCD, which facilitates import of vitamin B12
into Escherichia coli, was determined at 3.2-Å resolution (8). We
have now solved the crystal structure of E. coli BtuF, the cognate
periplasmic binding protein for BtuCD (9, 10) at 2.0-Å resolu-
tion. In addition, we could form a stable complex between BtuF
and BtuCD in vitro. These results provide general insights into
the interaction of binding proteins with their cognate ABC
transporters.
Materials and Methods
Purification and Crystallization. The btuf gene (previously yadt) was
amplified from E. coli genomic DNA. A construct with the
OmpA signal sequence and an N-terminal Strep-tag II preceding
the coding sequence of the mature form of BtuF was subcloned
into pET22b (Novagen). The protein was expressed in BL21
DE3 cells (Novagen) grown at 30°C in Terrific Broth supple-
mented with 100 gml ampicillin. The periplasmic extract from
4 g of BtuF-expressing cells was concentrated to 4 ml by using
Centriprep 10 concentrator units. The sample was dialyzed
overnight against 2 liters of 10 mM Tris (pH 7.5)25 mM NaCl
at room temperature and subsequently centrifuged to remove
precipitated protein. The supernatant was applied to a 1-ml
DEAE Sepharose column equilibrated in dialysis buffer and the
flow through, containing 90–95% pure BtuF, was collected.
Although present in the final construct, the Strep-tag II was not
used for purification. Vitamin B12 (cyanocobalamin, Sigma) was
added to a final concentration of 1 mM, and the sample was
concentrated to 15–20 mgml1. The ABC transporter BtuCD
was expressed and purified as described (8).
BtuF with bound vitamin B12 was crystallized at 4°C by vapor
diffusion in hanging drops containing 2 l of protein and 2 l of
reservoir solution [30% PEG 4000.1 M sodium acetate (pH
4.6)0.1 M cadmium chlorideHampton Crystal Screen 2, #12].
Ruby-red hexagonal bipyramidal crystals appeared within 3
days. Crystals were transferred to a 20-l drop of reservoir
solution containing5 mM vitamin B12, incubated for 5–15 min,
and frozen in liquid nitrogen. The crystals were in the space
group P65 (a  b  133.07 Å, c  67.69 Å) with two molecules
per asymmetric unit.
Data Collection and Structure Determination. Data were collected
from a single crystal at the Stanford Synchrotron Radiation
Laboratory beamline 9-2 at 100 K with a Quantum-315 CCD
(ADSC, Poway, CA) detector and processed using DENZO and
SCALEPACK (11). Experimental phases were obtained from a
three-wavelength multiwavelength anomalous diffraction
(MAD) experiment at the cobalt edge. The cobalt sites were
found using SOLVE (12) and their parameters refined with
SHARP (13). Solvent-f lattening, twofold noncrystallographic
symmetry (NCS) averaging and phase extension to 2.0 Å
were performed with DM (14), and the resulting maps, calcu-
lated using FFT (14), were of excellent quality. Anomalous
difference Fourier maps were used to visualize the B12-bound
cobalts as well as ordered cadmium and chlorine ions bound to
the surface of the protein. Cadmium versus chlorine ions were
distinguished by the intensities of the anomalous difference
Fourier peaks. Peaks in the anomalous difference Fourier map
were also observed at positions corresponding to sulfur atoms
in cysteine and methionine residues, and to the phosphorus
atom in each B12 molecule. The protein model was built using
O (15) and was refined against data combined from all
wavelengths by using CNS (16). NCS restraints were released
after initial rounds of refinement and each molecule was
refined separately. Model quality was verified using PROCHECK
Abbreviation: ABC, ATP binding cassette.
Data deposition: The atomic coordinates have been deposited in the Protein Data Bank,
www.rcsb.org (PDB ID code 1N2Z).
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Fig. 1. Structure of BtuF. A ribbon diagram of BtuF is shown in stereo with bound vitamin B12 in ball and stick. The N and C termini are labeled N and C,
respectively. The backbone -helix that bridges the two lobes of the protein is marked with an asterisk (see text).
Table 1. Statistics of data collection, phasing, and structure refinement
Data collection Peak Inflection Remote
Wavelength, Å 1.60268 1.60518 1.03317
Resolution, Å 20–2.0 20–2.0 20–2.0
Unique reflections 46,209 46,201 46,346
Redundancy 19.5 19.5 10.1
Completeness* 99.9 (98.7) 99.9 (98.5) 100 (100)
I(I)* 35.8 (7.7) 35.8 (7.4) 34.6 (11.1)
Rsym* 9.3 (28.8) 9.0 (29.0) 5.8 (18.2)
Phasing from Co MAD dataset
Resolution, Å 20–2.5
Isomorphous phasing power† from peak (centricacentric) 7.6111.93
Anomalous phasing power from peak (acentric) 2.22
Isomorphous phasing power from inflection (centricacentric) 7.6912.98
Anomalous phasing power from inflection (acentric) 2.06
Figure of merit (centricacentric) 0.820.82
Refinement
Resolution, Å 20–2.0
Reflections 41,592
Test reflections 4,651
Number non-H atoms 4,416
Rwork, % 0.189
Rfree, % 0.210
Average B factors, Å2
Protein 28.1
B12 25.5
Water molecules 38.5
CadmiumchlorinePEG 38.8
rms deviation (rmsd) bond
length, Å
0.0067
rmsd bond angles, ° 1.32
Ramachandran analysis
Most favored, % 90.7
Allowed, % 9.3
*Numbers in parentheses refer to the highest-resolution shell.
†Phasing power as calculated by SHARP (13).
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(17). The final model contains two molecules of BtuF including
residues 23–266 (the entire mature protein) plus one residue
at the N terminus from the Strep-tag II linker (Ala-22). The
model includes 377 water molecules, 22 cadmium and 6
chlorine ions, and 1 PEG400 molecule. The coordinates have
been deposited in the Protein Data Bank (PDB ID
code 1N2Z). Figs. 1, 2, and 4A were prepared using DINO
(www.dino3d.org).
Results and Discussion
Structure of BtuF and the Vitamin B12 Binding Site. The crystal
structure of E. coli BtuF with bound vitamin B12 was solved using
phases obtained from a MAD experiment at the cobalt edge.
Data collection, phasing, and refinement statistics are presented
in Table 1. BtuF has two structurally similar domains (lobes),
each consisting of a central five-stranded -sheet surrounded by
helices (Rossmann-like fold). The domains are connected by a
single ‘‘backbone’’ -helix spanning the length of the protein
(Fig. 1). This pattern of interdomain connectivity has also been
observed in the Mn2-binding protein PsaA from Streptococcus
pneumoniae (18), the Zn2-binding protein TroA from Trepo-
nema pallidum (19), and the ferrichrome binding protein FhuD
from E. coli (20). None of these binding proteins fall into the
previously defined Group I or Group II, characterized by three
or two interdomain connections, respectively (7), but instead
form a third Group, characterized by a single -helical segment
bridging the two lobes.
 single, well ordered molecule of vitamin B12 is bound in a
deep cleft between the two lobes of BtuF (Figs. 1 and 2). Similar
to B12 free in solution, BtuF-bound B12 exists in the ‘‘base-on’’
conformation, i.e., with the N3B nitrogen of the dimethylben-
zimidazole (DMB) base serving as an axial ligand to the central
cobalt atom. A similar conformation of bound B12 has been
observed in diol dehydratase (21) and class II ribonucleotide
Fig. 2. Stereo view of vitamin B12 bound to BtuF. (A) B12 is shown in ball and stick with carbon atoms in yellow, oxygens in red, nitrogens in blue, and phosphorus
in green. The central cobalt atom is depicted as a red sphere. The experimental electron density at 2-Å resolution is shown as a blue mesh contoured at 1.2 ,
whereas the anomalous difference Fourier density is shown as a red mesh and contoured at 8 . Cadmium and chlorine ions are shown as purple and green
spheres, respectively. (B) B12 binding site. The BtuF backbone is shown in black and the molecular surface of BtuF in transparent gray. Side chains of six aromatic
residues in van der Waals contact with B12 are colored green. B12 is shown as in A, whereas water molecules are depicted as light blue spheres.
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reductase (22). In contrast, B12 is bound in the base-off confor-
mation by methionine synthase (23), methylmalonyl-coA mutase
(24), and glutamate mutase (25). In these enzymes, the pseudo-
nucleotide tail of B12 is extended and the nitrogen of a nearby
histidine side chain acts as an axial ligand to the cobalt. Although
B12 is bound by BtuF in the base-on conformation, it is not
known whether passage through the BtuCD transporter requires
unfolding.
Six aromatic residues, three from each lobe of BtuF, contact
B12 in the binding site (Fig. 2B). Two of these, Trp-66 and -85,
are situated on either side of the DMB group. In this respect, the
binding site of BtuF resembles that of the ferrichrome binding
protein FhuD (20). A network of ordered waters is observed
between several corrin ring side chains and BtuF side and main
chain atoms at the bottom of the binding site. There are also
direct hydrogen bonds involving corrin ring side chains with the
main chain nitrogen of Ala-32 and the side chain atoms of
Asp-242 and Arg-246. Although cyanocobalamin was used in the
crystallization, no cyano group is apparent in the electron
density at the upper axial ligand position. Instead, strong peaks
in the anomalous difference Fourier map led us to model a
chlorine ion (from the crystallization solution) with associated
cadmium ions and water molecules (Fig. 2 A). Although these
ions occupy this space in the crystal structure, there appears to
be room for other axial ligands to the cobalt in vivo.
Conformational Dynamics in BtuF Structural Homologs. The release of
substrate into the translocation pathway of an ABC transporter is
undoubtedly coupled to conformational changes in the binding
protein (5, 7). In the absence of transporter, binding proteins such
as the maltose binding protein (MBP) exhibit large hinge and twist
movements of one lobe relative to the other between the liganded
and unliganded states (7). In contrast, binding proteins such as BtuF
and FhuD with a backbone -helix are thought to be less likely to
undergo such motions (18–20). Recently, the structure of one such
binding protein, T. pallidum TroA, was solved with (19) and without
(26) bound Zn2. The difference between liganded and unliganded
TroA was indeed found to be a mere 4° tilting of the C-terminal
domain about the long axis of the protein without bending or
unwinding of the backbone helix. This movement is very different
from that observed for MBP and yet the result is a partial collapse
of the binding site and the loss of the proper coordination geometry
for Zn2.
A search using the Dali server (27) revealed that there is a
striking structural similarity between the two lobes of BtuF and the
II and III domains of the molybdenum iron (MoFe) protein of
nitrogenase (Z 9.9 with 203 structurally equivalent residues; ref.
28). Analogous to vitamin B12 in BtuF, the iron-molybdenum
cofactor (FeMoco) is situated at the interface between the two
domains. In the absence of cofactor (29), one of the two protein
ligands to the FeMoco is shifted by 5 Å, and other segments of
the III domain are displaced or disordered, without a notable
hinge movement or bending of the helix that corresponds to the
backbone helix in BtuF. The differences in the structures of the
cofactor-free MoFe protein compared with the MoFe holoprotein
may be instructive for the potential conformational changes in
binding proteins during the transport cycle, because, analogous to
the rest of the MoFe protein, the membrane-spanning domains of
the ABC transporter may constrain the movements of the two lobes
of the attached binding protein.
BtuCD and BtuF Interact in Vitro. To show that the purified proteins
used to determine the crystal structures can interact, BtuF and
BtuCD were mixed at a molar ratio of 5:1 (binding protein:
transporter). A complex forms that is stable at 4°C for at least
72 h and can be isolated by size exclusion chromatography. The
presence of BtuF, BtuC, and BtuD was confirmed by gel
electrophoresis (Fig. 3) and the stoichiometry of the complex
(1 BtuF:2 BtuC:2 BtuD) was determined by densitometry of the
Coomassie-stained gel.
A Model for BtuF Docking to BtuCD. The availability of the crystal
structures of BtuF and BtuCD, combined with the evidence for
their docking in vitro, provides an opportunity to model the
interaction of an ABC transporter with its cognate binding protein.
Electrostatic surface potential maps reveal two negatively charged
‘‘knobs’’ near the apex of each BtuF lobe and two positively charged
‘‘pockets’’ on the periplasmic surface of BtuC. The knobs on the
surface of BtuF, corresponding to Glu-72 and -202, are 46 Å
apart, with the vitamin B12 binding site located halfway between
them. The pockets on BtuC are48 Å apart and are lined by three
arginine residues: Arg-56 and -59 from transmembrane helix TM2
and Arg-295 from TM9. Both glutamates and all three arginines are
conserved in iron siderophorecobalamin transport systems from
various organisms (Fig. 4 B and C), suggesting that these residues
may form interprotein salt bridges that are critical for proper
interaction of the binding protein with the transporter. When BtuF
is manually docked onto the periplasmic face of BtuCD, aligning
the conserved glutamates and arginines, bound B12 is positioned
over the entrance to the translocation pathway (Fig. 4A).
A competitive peptide mapping study of FhuB, an ABC
transporter for iron siderophores that is homologous to BtuCD,
provides independent biochemical support for the proposed
docking model of BtuF to BtuCD (30). It demonstrated that
several peptides derived from FhuB bind to its cognate binding
protein FhuD and inhibit transport of ferrichrome when intro-
Fig. 3. In vitro interaction of BtuF and BtuCD. (A) BtuF and BtuCD were mixed
in detergent solution (0.1% lauryldimethylamine-N-oxide) at a molar ratio of
5:1 in the presence of vitamin B12. The mixture was loaded onto an Superdex
200 1030 column (Amersham Pharmacia) with pure BtuF (dotted line) and
BtuCD (dashed line) as controls. Note that because of the presence of a large
detergent micelle, pure BtuCD elutes at essentially the same volume as the
complex of BtuCD and BtuF. (B) Peak fractions from the gel filtration chro-
matography shown in A were analyzed by SDSPAGE. Lane numbers corre-
spond to peaks as labeled in A. Note that BtuC runs as a doublet.
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duced into the periplasm. One of these peptides corresponds to
a loop on the periplasmic surface of BtuC located between the
conserved arginine pockets and the translocation pathway where
it could interact with BtuF.
Despite significant differences in architecture, salt bridges
may also play a crucial role for the interaction of the binding
proteins for maltose and histidine, MBP and HisJ, with their
cognate ABC transporters. When Glu-214, located near the
binding cleft of MBP, is mutated to lysine, maltose import is
significantly impaired in an in vivo transport assay, even though
binding of maltose to MBP appears unaffected (31). Similarly,
mutations in HisJ at residues Asp-144, Asp-149, and Arg-154 on
lobe II of HisJ, have been shown to inhibit histidine transport
with no significant effect on histidine binding (32). Mutation of
Asp-149 and Arg-154 also inhibits ATP hydrolysis by the
HisQMP2 transporter. In addition, chemical crosslinking studies
revealed that binding of these HisJ mutants to the membrane-
spanning subunit of the transporter, HisQ, was impaired. Al-
though there is no high-resolution structure of either the maltose
or histidine transporter, these mutation studies suggest that salt
bridges between surface-exposed residues may play an important
role in the attachment of binding proteins.
Conclusions
The structure of B12-bound BtuF reveals that vitamin B12 is
presented to the BtuCD transporter in the ‘‘base-on’’ conformation.
Conserved acidic residues on the surface of BtuF may be important
for interaction with BtuCD. Our observations provide a model for
the docking of a periplasmic binding protein to its cognate ABC
transporter. The ability to form a stable complex between BtuF and
BtuCD should allow their docking to be studied structurally, which
may reveal crucial conformational changes and provide a more
detailed understanding of the B12 transport reaction.
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